Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for acute musculoskeletal pain in children
ACTRN12612000012875Phase 4Completed
- Sponsor
- SouthernBiotech
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine in acute pain (2 cohorts), sponsored by SouthernBiotech. Primary endpoint: Mean change in pain score at 30 minutes. Started Feb 2012; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12612000012875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000012875.